Blog
Insights on clinical QA, vendor oversight, and the technology shaping pharma and biotech.
Articles
General
Best Practices for Maintaining Regulatory Compliance in Vendor Management and Oversight
Best practices for maintaining regulatory compliance in vendor management, including the real costs of inspection findings and how to prevent them.
Tom Lazenby General
Applying Principles of FDA Guidance for Industry Q9 Quality Risk Management 2023 to Vendor Risk Management
Applying the FDA's 2023 Q9 quality risk management guidance to clinical trial vendor oversight, from vendor selection through post-trial activities.
Tom Lazenby General
Vendor Level vs Study Level Vendor Risk Assessment: A Robust Approach
Understanding the difference between vendor-level and study-level risk assessments, and why both are essential for effective clinical trial oversight.
Tom Lazenby General
Welcome to Mayet: Spearheading change in Clinical Research Vendor Management
Introducing Mayet — an all-in-one vendor management platform built to streamline clinical trial outsourcing oversight for pharma and biotech sponsors.
Tom Lazenby